SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anavex Life Sciences Corp. – ‘10-Q’ for 3/31/19 – ‘EXCEL’

On:  Wednesday, 5/8/19, at 8:10pm ET   ·   As of:  5/9/19   ·   For:  3/31/19   ·   Accession #:  1615774-19-7324   ·   File #:  1-37606

Previous ‘10-Q’:  ‘10-Q’ on 2/7/19 for 12/31/18   ·   Next:  ‘10-Q’ on 8/7/19 for 6/30/19   ·   Latest:  ‘10-Q’ on 5/9/24 for 3/31/24   ·   13 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/09/19  Anavex Life Sciences Corp.        10-Q        3/31/19   38:3.3M                                   S2 Filings LLC/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    301K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     13K 
 3: EX-10.1     Material Contract                                   HTML     27K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
13: R1          Document and Entity Information                     HTML     42K 
14: R2          Interim Condensed Consolidated Balance Sheets       HTML     66K 
                (Unaudited)                                                      
15: R3          Interim Condensed Consolidated Balance Sheets       HTML     23K 
                (Unaudited) (Parenthetical)                                      
16: R4          Interim Condensed Consolidated Statements of        HTML     55K 
                Operations (Unaudited)                                           
17: R5          Interim Condensed Consolidated Statements of Cash   HTML     55K 
                Flows (Unaudited)                                                
18: R6          Interim Condensed Consolidated Statement of         HTML     67K 
                Changes in Stockholders' Equity (Unaudited)                      
19: R7          Business Description and Basis of Presentation      HTML     35K 
20: R8          Recent Accounting Pronouncements                    HTML     22K 
21: R9          Other Income                                        HTML     17K 
22: R10         Equity Offering Agreements                          HTML     24K 
23: R11         Commitments                                         HTML     73K 
24: R12         Subsequent Events                                   HTML     22K 
25: R13         Recent Accounting Pronouncements (Policies)         HTML     21K 
26: R14         Commitments (Tables)                                HTML     73K 
27: R15         Business Description and Basis of Presentation      HTML     16K 
                (Details Narrative)                                              
28: R16         Other Income (Details Narrative)                    HTML     16K 
29: R17         Equity Offering Agreements (Details Narrative)      HTML     49K 
30: R18         Commitments (Details)                               HTML     37K 
31: R19         Commitments (Details 1)                             HTML     55K 
32: R20         Commitments (Details 2)                             HTML     19K 
33: R21         Commitments (Details 3)                             HTML     24K 
34: R22         Commitments (Details Narrative)                     HTML     26K 
35: R23         Subsequent Events (Details Narrative)               HTML     36K 
37: XML         IDEA XML File -- Filing Summary                      XML     57K 
36: EXCEL       IDEA Workbook of Financial Reports                  XLSX     33K 
 7: EX-101.INS  XBRL Instance -- avxl-20190331                       XML    503K 
 9: EX-101.CAL  XBRL Calculations -- avxl-20190331_cal               XML     69K 
10: EX-101.DEF  XBRL Definitions -- avxl-20190331_def                XML    188K 
11: EX-101.LAB  XBRL Labels -- avxl-20190331_lab                     XML    431K 
12: EX-101.PRE  XBRL Presentations -- avxl-20190331_pre              XML    293K 
 8: EX-101.SCH  XBRL Schema -- avxl-20190331                         XSD     70K 
38: ZIP         XBRL Zipped Folder -- 0001615774-19-007324-xbrl      Zip     53K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


13 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/27/23  Anavex Life Sciences Corp.        10-K        9/30/23   54:5.7M                                   Electro Filings LLC/FA
 2/07/23  Anavex Life Sciences Corp.        424B5                  2:339K                                   Electro Filings LLC/FA
 1/27/23  Anavex Life Sciences Corp.        10-K/A      9/30/22    4:308K                                   Electro Filings LLC/FA
11/28/22  Anavex Life Sciences Corp.        10-K        9/30/22   49:5.1M                                   Electro Filings LLC/FA
11/24/21  Anavex Life Sciences Corp.        10-K        9/30/21   50:13M                                    Electro Filings LLC/FA
 9/24/21  Anavex Life Sciences Corp.        S-3ASR      9/24/21    3:489K                                   Electro Filings LLC/FA
 8/12/21  Anavex Life Sciences Corp.        10-Q        6/30/21   36:3M                                     Electro Filings LLC/FA
 6/24/21  Anavex Life Sciences Corp.        424B5                  1:267K                                   Electro Filings LLC/FA
 4/09/21  Anavex Life Sciences Corp.        S-8         4/09/21    3:71K                                    Electro Filings LLC/FA
 2/16/21  Anavex Life Sciences Corp.        424B5                  1:299K                                   Electro Filings LLC/FA
 2/16/21  Anavex Life Sciences Corp.        10-Q       12/31/20   39:2.8M                                   Electro Filings LLC/FA
12/28/20  Anavex Life Sciences Corp.        10-K        9/30/20   44:3.6M                                   Electro Filings LLC/FA
 8/06/20  Anavex Life Sciences Corp.        10-Q        6/30/20   36:2.5M                                   Electro Filings LLC/FA
Top
Filing Submission 0001615774-19-007324   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 11:18:01.2am ET